
The price history is unavailable right now.
| 1W | 1M | 6M | 1Y | 5Y | |
|---|---|---|---|---|---|
| Stock | - | - | - | - | - |
| SPY | - | - | - | - | - |
Historical total returns · Dividends reinvested
No weak spot in its numbers right now.
Loading…
In 3 copy portfolios. See which with Premium
No company summary is available right now.
Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035Yahoo Finance · 6 h ago
Amgen (AMGN) Just Gave Investors Something To Think AboutYahoo Finance · 24 h ago
Is Amgen Stock Still Telling Investors The Same Thing?trefis.com · 2 d ago
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?The Motley Fool · 4 d ago